Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation.
- Published in:
- Oncogene, 2013, v. 32, n. 5, p. 663, doi. 10.1038/onc.2012.67
- By:
- Publication type:
- Article
Works matching IS 09509232 AND DT 2013 AND VI 32 AND IP 5
Results: 14
1
2
Alveolar rhabdomyosarcoma-associated proteins PAX3/FOXO1A and PAX7/FOXO1A suppress the transcriptional activity of MyoD-target genes in muscle stem cells.
- Published in:
- Oncogene, 2013, v. 32, n. 5, p. 651, doi. 10.1038/onc.2012.73
- By:
- Publication type:
- Article
3
The Greatwall kinase: a new pathway in the control of the cell cycle.
- Published in:
- Oncogene, 2013, v. 32, n. 5, p. 537, doi. 10.1038/onc.2012.79
- By:
- Publication type:
- Article
4
Minor cell-death defects but reduced tumor latency in mice lacking the BH3-only proteins Bad and Bmf.
- Published in:
- Oncogene, 2013, v. 32, n. 5, p. 621, doi. 10.1038/onc.2012.78
- By:
- Publication type:
- Article
5
The WRN and MUS81 proteins limit cell death and genome instability following oncogene activation.
- Published in:
- Oncogene, 2013, v. 32, n. 5, p. 610, doi. 10.1038/onc.2012.80
- By:
- Publication type:
- Article
6
CD133<sup>+</sup> cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancer.
- Published in:
- Oncogene, 2013, v. 32, n. 5, p. 544, doi. 10.1038/onc.2012.85
- By:
- Publication type:
- Article
7
The role of TRKA signaling in IL-10 production by apoptotic tumor cell-activated macrophages.
- Published in:
- Oncogene, 2013, v. 32, n. 5, p. 631, doi. 10.1038/onc.2012.77
- By:
- Publication type:
- Article
8
Synthetic lethality of Chk1 inhibition combined with p53 and/or p21 loss during a DNA damage response in normal and tumor cells.
- Published in:
- Oncogene, 2013, v. 32, n. 5, p. 577, doi. 10.1038/onc.2012.84
- By:
- Publication type:
- Article
9
EpCAM regulates cell cycle progression via control of cyclin D1 expression.
- Published in:
- Oncogene, 2013, v. 32, n. 5, p. 641, doi. 10.1038/onc.2012.75
- By:
- Publication type:
- Article
10
Oncogenic KRAS and BRAF activation of the MEK/ERK signaling pathway promotes expression of dual-specificity phosphatase 4 (DUSP4/MKP2) resulting in nuclear ERK1/2 inhibition.
- Published in:
- Oncogene, 2013, v. 32, n. 5, p. 564, doi. 10.1038/onc.2012.88
- By:
- Publication type:
- Article
11
SIRT1 deacetylase promotes acquisition of genetic mutations for drug resistance in CML cells.
- Published in:
- Oncogene, 2013, v. 32, n. 5, p. 589, doi. 10.1038/onc.2012.83
- By:
- Publication type:
- Article
12
FOXA1 represses the molecular phenotype of basal breast cancer cells.
- Published in:
- Oncogene, 2013, v. 32, n. 5, p. 554, doi. 10.1038/onc.2012.62
- By:
- Publication type:
- Article
13
Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8.
- Published in:
- Oncogene, 2013, v. 32, n. 5, p. 599, doi. 10.1038/onc.2012.81
- By:
- Publication type:
- Article
14
Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling.
- Published in:
- Oncogene, 2013, v. 32, n. 5, p. 670, doi. 10.1038/onc.2012.559
- By:
- Publication type:
- Article